Access brought to you by: LOCKSS

Hepatology

HCV—Infected Patients with Compensated Cirrhosis Benefit from 12-Week, Once-Daily, Oral Combination of LDV and SOF
100% SVR with Ledipasvir/Sofosbuvir Plus Ribavirin in Patients with HCV GT-1 Failing Prior Therapy
High Efficacy Rates with Grazoprevir Plus Elbasvir in HCV Monoinfection and HCV/HIV Coinfection
Interferon- and RBV-Free Treatment with LDV and SOF is Efficacious in Patients Coinfected with HCV and HIV
Prednisolone but Not PTX Improves 28-Day Mortality in Patients with Alcoholic Hepatitis
New Treatments for Hepatitis C
DCV/ASV/BCV Improves Sustained Viral Response in Patients with Chronic HCV GT-1 Infection and Compensated Cirrhosis: UNITY-2 Results
Accurate Diagnosis and Appropriate Treatment Beneficial for HRS and AIH
Combination DCV/SOF is Effective in Achieving Sustained Response in Patients with HCV GT-3
Current and Soon-to-Be-Approved Regimens Offer High Cure Rates for HCV

Pages